Subscribe to RSS
DOI: 10.1055/s-0028-1087939
Chirality Transfer in Azetidinium Ylides: An Enantioselective Route to α-Quaternary Azetidines
Publication History
Publication Date:
24 February 2009 (online)
Abstract
Enantiomerically pure N-allyl azetidinium ions undergo a stereoselective [2,3]-sigmatropic shift to give azetidines with an α-quaternary center. These compounds are direct precursors of 2-alkyl-2-carboxy-azetidines, a new class of constrained α-amino acids.
Key words
azetidines - nitrogen ylides - α-quaternary amino acids
- 1 For a recent review on this topic,
see:
Calaza MI.Cativiela C. Eur. J. Org. Chem. 2008, 3427 - 2
Seebach D.Sting AR.Hoffmann M. Angew. Chem., Int. Ed. Engl. 1996, 35: 2708 - 3
Baeza JL.Gerona-Navarro G.Pérez de Vega MJ.García-López MT.Gonzàles-Muñiz R.Martín-Martínez M. Tetrahedron Lett. 2007, 48: 3689 - 4
Gerona-Navarro G.Bonache MA.Alías M.Pérez de Vega MJ.García-López MT.Cativiela C.Gonzàles-Muñiz R. Tetrahedron Lett. 2004, 45: 2193 - 5
Gerona-Navarro G.García-López MT.Gonzàles-Muñiz R. J. Org. Chem. 2002, 67: 3953 - 6
Kawabata T.Matsuda S.Kawakami S.Monguchi D.Moriyama K. J. Am. Chem. Soc. 2006, 128: 15394 - 7
Couty F.Evano G.Prim D. Mini-Rev. Org. Chem. 2004, 1: 133 - 8
Couty F.Evano G. Org. Prep. Proced. Int. 2006, 38: 427 -
9a
Couty F.Evano G.Vargas-Sanchez M.Bouzas G.
J. Org. Chem. 2005, 70: 9028 -
9b
Braüner-Osborne H.Bunch L.Chopin N.Couty F.Evano G.Jensen AA.Kusk M.Nielsen B.Rabasso N. Org. Biomol. Chem. 2005, 3: 3926 -
9c
Mangaleshwaran S.Couty F.Evano G.Srinivas B.Sridhar R.Rama Rao K. ARKIVOC 2007, (x): 71 -
10a
Couty F.David O.Larmanjat B.Marrot J. J. Org. Chem. 2006, 72: 1058 -
10b
Alex A.Larmanjat B.Marrot J.Couty F.David O. Chem. Commun. 2007, 2500 - 11
Glaeske KW.West FG. Org. Lett. 1999, 1: 31 - 12
Lumini M.Cordero FM.Pisanechi F.Brandi A. Eur. J. Org. Chem. 2008, 2817 - 13
Khlebnikov AF.Novikov MS.Kostikov RR. Russ. Chem. Rev. 2005, 74: 171 - 14
Couty F.Durrat F.Evano G.Prim D. Tetrahedron Lett. 2004, 45: 7525 - 15
Agami C.Couty F.Evano G. Tetrahedron: Asymmetry 2002, 297 - 16
Beard CD.Baum K.Grakauskas V. J. Org. Chem. 1973, 38: 3673 - 18
Couty F.Durrat F.Prim D. Tetrahedron Lett. 2003, 44: 5209 - 20
Drouillat B.Couty F.David O.Evano G.Marrot J. Synlett 2008, 1345 - 21
Couty F.Durrat F.Evano G.Marrot J. Eur. J. Org. Chem. 2006, 4214 - 22
Cospito G.Illuminati G.Lilloci C.Petride H. J. Org. Chem. 1981, 46: 2944 - 24 For a recent review on the reductive
decyanation, see:
Mattalia J.-M.Marci-Delapierre C.Hazimeh H.Chanon M. ARKIVOC 2006, (iv): 90
References and Notes
Compounds 17 and 20 were obtained as a 6:4 ratio of epimers by anionic cyclization of the corresponding chloride, obtained following a similar synthetic sequence as the one described in Scheme [¹] . Compound 22 was obtained as the major epimer (7:3 ratio) following Scheme [¹] .
19This ester was prepared by reaction of the corresponding nitrile (ref. 9a) in a mixture of EtOH-H2SO4 (yield 83%).
23The crystal structure data have been deposited at the Cambridge Crystallographic Data Centre and allocated the deposition number CCDC 703601.
25
General Procedure
for Rearrangement of Azetidinium Triflates
The following
procedure for the preparation of azetidine 13 is
representative. To a solution of azetidinium triflate 10 (823 mg, 2.19 mmol) in dry THF (40 mL),
cooled at -78 ˚C was added in one portion
KOt-Bu (300 mg, 2.67 mmol). The reaction
mixture was allowed to reach 0 ˚C over 3 h and
was quenched by addition of H2O and Et2O.
The reaction mixture was extracted with Et2O, the combined
organic layers were washed with brine, dried over MgSO4,
and concentrated under reduced pressure. The crude residue was examined
by ¹H NMR and showed a diastereomeric ratio
of 98:2. Purification by flash chromatography (cyclohexane-EtOAc, 8:2)
gave 13 as a colorless oil (461mg, 93%).
Selected Data
Compound 13: R
f
= 0.48
(cyclohexane-EtOAc, 8:2); [α]D
²5 -13.1
(c 0.33, CHCl3). ¹H
NMR (300 MHz,CDCl3): δ = 1.42 (d, J = 6.6 Hz,
3 H, Me), 2.01-2.12 (m, 1 H, CHHCH=CH2), 2.21-2.32
(m, 1 H, CHHCH=CH2),
2.42 (s, 3 H, NMe),
3.65 (d, J = 5.4
Hz, 1 H, H3), 3.80 (q, J = 5.5
Hz, 1 H, H4), 4.85-5.03 (m, 2 H, CHHCH=CH
2), 5.35-5.52 (m,
1 H, CHHCH=CH2),
7.23-7.35 (m, 5 H, Ar). ¹³C
NMR (75 MHz, CDCl3): δ = 17.2 (CH3),
33.9 (NMe), 36.3 (CH2), 53.3 (C3), 61.9 (C4), 64.9 (C2),
119.9 (CN), 121.1 (CH=CH2),
126.9, 128.3, 129.1 (CHAr), 131.0 (CH=CH2),
135.6 (CqAr). MS (CI, NH3): m/z = 227.1
(100) [MH+], 200.2 (50) [MH+ - HCN].
Compound 14; yield 73%, colorless oil; R
f
= 0.34
(pentane-EtOAc, 9:1); [α]D
²5 -64
(c 1, CH2Cl2). ¹H
NMR (300 MHz, CDCl3): δ = 1.17 (d, J = 5.8 Hz,
3 H, Me), 2.38 (s, 3 H, NMe), 2.58 (appt. d, J = 5.3
Hz, 2 H, CH
2
CH=CH2),
3.15
(d, J = 9.1
Hz, 1 H, H3), 3.35 (q, J = 5.8
Hz, 1 H, H4),
5.11-5.22 (m, 2 H, CHHCH=CH
2), 5.70-5.84 (m,
1 H, CHHCH=CH2),
7.12-7.21 (m, 5 H, Ar). ¹³C
NMR (75 MHz, CDCl3 MHz): δ = 19.6 (CH3),
37.9 (NMe), 43.8 (CH2), 53.9 (C3), 63.5 (C4), 71.2 (C2),
117.2 (CN), 120.2 (CH=CH2), 127.8,
128.3, 128.6 (CHAr), 130.9 (CH=CH2),
135.3 (CqAr). MS (CI, NH3): m/z = 227.1
(100) [MH+], 200.2 (35) [MH+ - HCN].